Scientific article
OA Policy
English

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

Published in

Haematologica, vol. 96, no. 6, p. 896-904

Publication date

2011

Abstract

Responses to influenza vaccines are poorly characterized in immunocompromised patients. The goal of this study was to assess the efficacy of the AS03-adjuvanted influenza H1N1/A/09 vaccine in allogeneic hematopoietic stem cell transplant recipients.

Keywords

  • Adult
  • Aged
  • Antibodies, Viral/blood/immunology
  • Antibody Formation/immunology
  • Female
  • Graft vs Host Disease/immunology
  • Hematopoietic Stem Cell Transplantation/adverse effects
  • Humans
  • Immunity, Humoral/immunology
  • Immunization
  • Immunocompromised Host
  • Influenza Vaccines/adverse effects/immunology
  • Male
  • Middle Aged
  • Transplantation, Homologous/immunology
  • Young Adult

Citation (ISO format)

Geneva University Hospitals H1N1 study group. Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. In: Haematologica, 2011, vol. 96, n° 6, p. 896–904. doi: 10.3324/haematol.2011.040386

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0390-6078
1066views
704downloads

Technical informations

Creation

06/11/2012 12:03:00

First validation

06/11/2012 12:03:00

Update

09/02/2026 15:42:43

Status update

09/02/2026 15:42:43

Last indexation

10/11/2026 16:53:14
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated